XNAS · Healthcare · Medical Instruments & Supplies
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Patent litigation against E2 adds a meaningful competitive defense in thrombectomy, but the quarter itself was merely decent: revenue was **$87M** and EPS **-$0.07**, both ahead of estimates, while management still guides to a **-$0.30 to -$0.23** loss.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 | Q4 2026 | -0.09 | -0.07 | +22.22% | $86.6M | ✅ Beat | — | — | — |
| 2026-04-02 | Q3 2026 | -0.11 | -0.07 | +36.36% | $78.4M | ✅ Beat | +0.00% | -2.13% | +8.24% |
| 2026-01-06 |
| Q2 2026 |
| -0.10 |
| 0.00 |
| +100.00% |
| $79.4M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-10-02 | Q1 2026 | -0.13 | -0.10 | +23.08% | $75.7M | ✅ Beat | — | — | — |
| 2025-07-15 | Q4 2025 | -0.12 | -0.03 | +75.00% | $80.2M | ✅ Beat | — | — | — |
| 2025-04-02 | Q3 2025 | -0.13 | -0.08 | +38.46% | $72.0M | ✅ Beat | — | — | — |
| 2025-01-08 | Q2 2025 | -0.11 | -0.04 | +63.64% | $72.8M | ✅ Beat | — | — | — |
| 2024-10-03 | Q1 2025 | -0.15 | -0.11 | +26.67% | $67.5M | ✅ Beat | — | — | — |
Showing last 8 quarters.